We analysed the causes of 67 deaths, over a 4 y period, in our oriental population with systemic lupus erythematosus (SLE). The median disease duration was 48±60.5 months (range 1—250 months). The mean age at diagnosis and death were 30 and 35.1 y respectively. SLE alone accounted for death in 30 patients (44.8%), infection in 27 (40.3%), pulmonary embolism in 5 (7.5%), malignancy in 4 (5.9%) and rheumatic heart disease in 1 (1.5%). The major organ involvement in those with active disease at death were SLE related thrombocytopenia (n = 23/44, 52.3%), nephritis (n=21/44), 47.7%), cerebral lupus ( n=16/44, 36.4%), and pulmonary haemorrhage (n=12/44, 27.3%). As in other series, SLE and infection were the principal causes of death in our population. During this 4 y period, there was no late death due to atherosclerosis.
Merrell M., Shulman LEDetermination of prognosis in chronic disease illustrated by systemic lupus erythematosus. J Chronic Dis1955; 1: 12-32.
2.
Kellum RE, Hasericke JRSystemic lupus erythematosus: A statistical evaluation of mortality based on a consecutive series of 299 patients. Arch Intern Med1964; 113: 200-207.
3.
Estes D., Christian C.The natural history of systemic lupus erythematosus by prospective analysis . Medicine (Baltimore)1971; 50: 85-95.
4.
Urowitz MB et al. The bimodal mortality pattern of systemic lupus erythematosus . Am J Med1976; 60: 221-225.
5.
Wallace DJ et al. Systemic lupus erythematosus: survival patterns: experience with 609 patients. JAMA1981; 245: 934-938.
6.
Ginzler EM et al.. A multicenter study of outcome in systemic lupus erythematosus . I. Entry variables as predictors of prognosis. Arthritis Rheum1982; 25(6): 601-611.
7.
Jonsson H., Nived O., Sturfelt G.Outcome in systemic lupus erythematosus: A prospective study of patients from a defined population. Medicine (Baltimore)1989; 68(3): 141-150.
Swaak Ajg et al. Systemic lupus erythematosus: I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis1989; 48: 447-454.
10.
Reveille JD , Bartolucci A., Alarcon GSPrognosis in Systemic Lupus Erythematosus: Negative impact of increasing age at onset, black race and thrombocytopenia as well as causes of death. Arthritis Rheum1990; 33(1): 37-48.
11.
Gripenberg M., Helve T.Outcome of systemic lupus erythematosus: A study of 66 patients over 7 years with special reference to the predictive value of anti-DNA antibody determination. Scand J Rheumatol1991; 20: 104-109.
12.
Pistiner M. et al. Lupus erythematosus in the 1980s: A survey of 570 patients. Semin Arthritis Rheum1991 ; 21: 55-64.
13.
Seleznick MJ , Fries JFVariables associated with decreased survival in systemic lupus erythematosus. Semin Arthritis Rheum1991; 21: 73-80.
14.
Gladman DDPrognosis of systemic lupus erythematosus and the factors that affect it. Curr Opin Rheumatol1992; 4: 681-687.
15.
Kumar A. et al. Survival in patients with systemic lupus erythematosus in India . Rheumatol Int1992; 12: 107-109.
16.
Rubin LA, Urowitz MB, Gladman DDMortality in systemic lupus erythematosus: the bimodal pattern revisited . Q J Med1985; 55(216): 87-98.
17.
Ginzler EM, Schom K.Outcome and prognosis in systemic lupus erythematosus. Rheum Dis Clin North Am1988; 14: 67-78.
18.
Ward MM, Pyun E., Studenski S.Causes of death in Systemic Lupus Erythematosus. Long term follow up of an inception cohort. Arthritis Rheum1995; 38(10): 1492-1499.
19.
Formiga Perez F. et al. Infection and systemic lupus erythematosus: analysis of a series of 145 patients. Revista Clinica Espanola1993; 193(3): 105-109.
20.
Massardo L. et al. Infections in systemic lupus erythematosus. Revista Medica de Chile1991; 119(10): 1115-1122.
21.
Duffy KN, Duffy CM, Gladman DDInfection and disease activity in systemic lupus erythematosus: a review of hospitalised patients. J Rheum1991 ; 18(8): 1180-1184.
22.
Cohen MG, Li EKMortality in systemic lupus erythematosus: active disease is the most important factor. Aust NZ J Med1992; 22(11): 5-8.
23.
Studenski S. et al. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum1987; 3012: 1326-1332.
24.
Kaslow RAHigh rate of death caused by systemic lupus erythematosus among U.S. residents of Asian descent. Arthritis Rheum1982; 25(4): 414-418.
25.
Samanta A. et al. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis1991; 50(7): 490-492.
26.
Dubois EL et al. Duration and death in SLE: An analysis of 249 cases. JAMA1974; 227: 1399-1402.
27.
Ward MM, Pyun E., Studenski S.Long term survival in systemic lupus erythematosus. Arthritis Rheum1995; 38(2): 274-283.
28.
Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271-1277.
29.
Lee SS, Li CS, Li Pck.Clinical profile of Chinese patients with systemic lupus erythematosus . Lupus1993; 2: 105-109.
30.
Massardo L. et al. Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum1994; 24(1): 1-11.
31.
Nossent JC, Swaak Ajg.Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med1991 ; 80: 605-612.
32.
Boey ML, Ng SC, Feng PHMortality of orientals with systemic lupus erythematosus - a reappraisal. Singapore Med J1987; 28(4): 318-320.
33.
Petri M. et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med1992; 93: 513-519.
34.
Drenkard C. et al. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheum1994; 21(6): 1067-1072.
35.
Pattersson T. et al. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis1992; 51: 437-439.
36.
Canoso JJ, Cohen ASMalignancy in a series of 70 patients with systemic lupus erythematosus . Arthritis Rheum1974; 17: 383-390.
